Clinical Trial Update: TSN084 Treating Patients With Advanced Malignant Tumors [Phase 1]

View source ↗

Summary

This clinical trial update reports that TSN084 is being studied in patients with advanced malignant tumors in Phase 1 and is currently recruiting. The sponsor i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Neoplasm

Drugs mentioned

• TSN084

Snippet

Sponsor: Tyligand Bioscience (Shanghai) Limited | Conditions: Malignant Neoplasm | Phase 1 | Status: RECRUITING